| Mr Dennis Dunn |
Trust Chairman | |||||
|---|---|---|---|---|---|---|
| Mr John Church | Deputy Chair | |||||
| Mrs Lorraine Butcher | Non-Executive | |||||
| Mrs Lesley Massey | Non-Executive | |||||
| Mr Trevor Brocklebank | Non-Executive | |||||
| Mr Les Philpott | Non-Executive | |||||
| Mr Andy Vernon | Non-Executive | |||||
| Mr James Sumner | Chief Executive | |||||
| Mr Russ Favager | Director of Finance |
and | Planning | gt Deputy | Chief | |
| Executive | ||||||
| Mrs Heather Barnett |
Director ofWorkforce | |||||
| Mrs Julie Tunney | Director of Nursing | and Quality | ||||
| Mr Chris Oliver | Chief Operating | Officer (to | 30.06.2020) | |||
| Mr Oliver Bennett | Chief Operating | Officer (from 20.07.2020) | ||||
| Mr Murray Luckas |
Medical Director | |||||
| Mrs Denise Frodsham | Director ofStrategic | Partnerships |
| 2020/21 | 2019/20 | ||||
|---|---|---|---|---|---|
| Unrestricted | Total | Unrestricted | Total | ||
| '000 | '000 | '000 | '000 | ||
| Income | |||||
| Donations (note 2) | 462 | 462 | 195 | 195 | |
| Legacies | 78 | 78 | 305 | 305 | |
| Investment Income (note 3) |
12 | 12 | 13 | 13 | |
| Total | 552 | 552 | 513 | 513 | |
| Expenditure | |||||
| Cost ofraising Funds (Note 4) | -48 | -48 | -39 | -39 | |
| Charitable Activities (Note 5) |
-452 | -452 | -251 | -251 | |
| Tata I |
-500 | -500 | -290 | -290 | |
| Net gains/(losses) on Investments |
80 | 80 | -52 | -52 | |
| Net Expenditure | 132 | 132 | 171 | 171 | |
| Transfers between Funds |
|||||
| Net Movement in Funds |
132 | 132 | 171 | 171 | |
| Reconciliation ofFunds | |||||
| Total Funds Brought Forward | 1,019 | 1,019 | 848 | 848 | |
| Total Funds Carried Forward | 1,151 | 1,151 | 1,019 | 1,019 |
| 2020/21 | 2019/20 | |||
|---|---|---|---|---|
| Unrestricted | Total | Unrestricted | Total | |
| '000 | '000 | '000 | '000 | |
| Fixed Assets | ||||
| Investments (Note 7) |
671 | 671 | 582 | 582 |
| Total fixed assets | 671 | 671 | 582 | 582 |
| Current Assets | ||||
| Debtors (Note 9) | 47 | 47 | 27 | 27 |
| Cash at Bank (Note 8) | 532 | 532 | 448 | 448 |
| Total current assets | 579 | 579 | 475 | 475 |
| Liabilities | ||||
| Creditors falling due within one year (Note 10) | -99 | -99 | -38 | -38 |
| Total Liabilities or provisions | -99 | -99 | -38 | -38 |
| Net current assets or liabilities | 480 | 480 | 437 | 437 |
| Total net assets | 1151 | 1151 | 1019 | 1019 |
| Funds ofthe Charity (Note 11) | ||||
| Unrestricted Funds |
1,151 | 1,151 | 1019 | 1019 |
| 1151 | 1,151 | 1019 | 1019 |
| Dennis Dorm MBEJP DL |
Date 01.10.21 |
|---|---|
| Chairman | |
| Russ Favager | 01/10/2021 |
| Director of Finance and Planning: | Date ... |
| Total funds | Prior year funds | ||||||
|---|---|---|---|---|---|---|---|
| '000 | '000 | ||||||
| Cash Flows from operating | activities: | ||||||
| Net cash provided by (used in) operating |
activities | 134 | 450 | ||||
| Cash flows from Investing | Activities | ||||||
| Dividends from Investments |
( note 3) | 12 | 13 | ||||
| Proceeds from sale of investments (note |
7) | 292 | 80 | ||||
| Purchase ofinvestments ( |
note 7) | -351 | -95 | ||||
| Investment fees (note 4) |
-3 | -3 | |||||
| Net cash provided by(used |
in)investing | activities | -50 | -5 | |||
| Change in cash and cash equivalents |
in year | 84 | 445 | ||||
| Cash and cash equivalents | as at 1st April | 2020 | 448 | ||||
| Cash and cash equivalents | as at 31st | March 2021 | 532 | 448 |
| 2020/21 | 2019/20 | ||||||
|---|---|---|---|---|---|---|---|
| '000 | '000 | ||||||
| Net income/(expenditure) | for 2020/21 as | per SOFA | 132 | 171 | |||
| (Gains)/Loss on Investments |
-30 | 55 | |||||
| Dividends | -12 | -13 | |||||
| (Increase)/Decrease | in Debtors | -20 | 280 | ||||
| Increase/(Decrease) | in Creditors | 61 | -34 | ||||
| Increase/(Decrease) | in Provisions | 0 | -12 | ||||
| Investment Fees |
3 | 3 | |||||
| Net Cash provided | by/(used | in) Operating | Activities | 134 | 450 |
| Note 2r I | ncome fro | m Donations | ||||
|---|---|---|---|---|---|---|
| 2020/21 | 2019/20 | |||||
| '000 | '000 | |||||
| Donations from public | 71 | 175 | ||||
| Memodial | Donations | 3D | 16 | |||
| In aid of | Fundraising | 66 | ||||
| NH5 Charities together grants | 170 | |||||
| garclays | Chaditable | Grant | 125 | |||
| 462 | 195 |
| Note 3EInvestment | Note 3EInvestment | Income | Income | ||||
|---|---|---|---|---|---|---|---|
| 2020/21 | 2019/20 | ||||||
| '000 | '000 | ||||||
| Dividends | on Investments | 12 | 13 | ||||
| 12 | 13 | ||||||
| Note 4:Cost of Raising | funds | ||||||
| 2020/21 | 2019/20 | ||||||
| '000 | 'DDD | ||||||
| Investment | Managers | Fees | |||||
| Fundralslng | Management | 45 | 36 | ||||
| 39 |
| 2020/21 | 2019/20 | ||||||
|---|---|---|---|---|---|---|---|
| Unrestricted | Total | Unrestricted | Total | ||||
| Direct contribution to Patient Welfare |
|||||||
| Additonal Equipment |
216 | 216 | 107 | 107 | |||
| Enhancement ofpatient |
experience | 13 | 23 | 23 | |||
| Improvement ofpatient |
facilities | 22 | 22 | ||||
| Direct Contdibution to staff Welfare |
|||||||
| Educational opportunites |
for staff | 23 | |||||
| Improvement to staff facilites |
66 | 66 | |||||
| Recognition ofstaff achievements | 45 | 45 | 12 | ||||
| snppolt costs | 75 | 75 | 74 | 74 | |||
| Total Expenditure | 452 | 452 | 251 | 251 |
| Note 6:Analysis ofSupport Costs | Note 6:Analysis ofSupport Costs | Note 6:Analysis ofSupport Costs | ZD20/21 | 2019/20 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Charitable | gasis of | Charitable | ||||||||||||
| Raising | Funds | Activities | Total | Allocation | Raising Funds | Activities | Total | |||||||
| Unrestncted | Unrestricted | Unrestricted | Unrestricted | |||||||||||
| Apportionment | ||||||||||||||
| Governance | 10 | 10 | on average fund | |||||||||||
| balance | ||||||||||||||
| Apportionment | ||||||||||||||
| Audit Fee | 5 | on averagefund | ||||||||||||
| balance | ||||||||||||||
| Apportionment | ||||||||||||||
| Financesupport | 14 | 14 | on average fund | 13 | ||||||||||
| balance | ||||||||||||||
| Apportionment | ||||||||||||||
| Information | Technology | 5 | on average fund | 10 | ||||||||||
| balance | ||||||||||||||
| Allocated on | ||||||||||||||
| Human | Resources | 55 | time and average fund |
32 | 49 | 81 | ||||||||
| balance | ||||||||||||||
| Tote Is | 48 | 75 | 123 | 39 | 74 | 113 |
| Note 7r Fixed | Asset Movements | - Investments | 20120/21 | 2019/20 | |
|---|---|---|---|---|---|
| 'ODO | '000 | ||||
| Market Value | as at 1st April 2020 | 582 | 622 | ||
| Add: Additions to Investments | at cost | 351 | 95 | ||
| Less:Sales at | carrying value | -292 | -80 | ||
| Less: Net (loss)/gain on revaluation |
30 | -55 | |||
| Market value | as at 31st March | 2021 | 671 | 582 | |
| Historic cost | of Investments at |
31st March | E605K | ||
| Investments | at Market value comprised: | 2020/21 | 2019/20 | ||
| 'OOD | 'OOD | ||||
| Equities listed on UK stock exchange |
657 | 546 | |||
| UK Money market investments | 14 | 36 | |||
| 671 | 582 | ||||
| Note 8i Analysis ofcash and cash equivalents | |||||
| 2021/22 | 2019/20 | ||||
| '000 | '000 | ||||
| Cash in hand | 532 | 448 | |||
| Total Cash end cash equivalents | 532 | ||||
| 23 |
| Note 9IAnalysis ofDebtors | Note 9IAnalysis ofDebtors | 2020/21 | 2019/20 | ||
|---|---|---|---|---|---|
| 000 | '000 | ||||
| HMHC Gift | aid | ||||
| Confirmed | Legacies | 43 | 19 | ||
| 47 | 27 |
| Note 10:Analysis | ofCreditors | faging within one year | 2020/21 | 2019/20 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| '000 | '000 | |||||||||||
| Funds due to MCHT | 99 | 38 | ||||||||||
| 99 | 38 | |||||||||||
| Note 11:Analysis | of Charitable | Funds | ||||||||||
| 2020/21 | Balance 9/fwd | Income | Expenditure | Transfers | losses | Fund c/fwd | ||||||
| 01.03.2020 | 20/21 | 20/21 | 20/21 | 20/21 | 31.03.2021 | |||||||
| '000 | '000 | '000 | '000 | '000 | '000 | |||||||
| Unrestricted Funds |
||||||||||||
| Leighton Hospital |
Ik Victoria Infirmary | 1019 | 954 | -902 | BD | 1151 | ||||||
| 1019 | 954 | 902 | 0 | 80 | 1'151 | |||||||
| Significant Balances offunds held as at 31st March 2021 |
||||||||||||
| Dementia Appeal |
6131K | |||||||||||
| Leighton General | E307K | |||||||||||
| Health ILWell being Fund |
E235K | |||||||||||
| Other Funds | E478K | |||||||||||
| 2019/20 | Balance 8/fwd | Income | Expenditure | Transfers | losses | Fund c/fwd | ||||||
| 01.03.2019 | 19/20 | 19/2D | 19/20 | 19/20 | 31.03.2020 | |||||||
| '000 | 'ODO | '000 | '000 | '000 | 'OOD | |||||||
| unrestricted Funds |
||||||||||||
| Leighton Hospital |
Ik Victoria Infirmary | 513 | -29D | -69 | 17 | 1019 | ||||||
| 513 | -290 | -69 | 17 | 1019 | ||||||||
| Significant Balances offunds held as at 31st March 2020 |
||||||||||||
| Dementia Appeal |
6226K | |||||||||||
| Leighton General | 6331K | |||||||||||
| Cancer Services | 91K | |||||||||||
| Other Funds | E371K |